Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
10/2003
10/22/2003EP1354873A1 Salt of perindopril and pharmaceutical compositions containing it
10/22/2003EP1354604A1 Combinations for cardiovascular indications
10/22/2003EP1354595A1 Composition containing extracts of butyrospermum parkii and its use as medicament or dietary supplement
10/22/2003EP1354214A2 Mri method involving the use of a hyperpolarized contrast agent
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353694A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
10/22/2003EP1150661B1 Topical sprays comprising a film forming composition
10/22/2003EP1047665B1 Matrix metalloprotease inhibitors
10/22/2003EP0910330B1 Hair dye compositions and process
10/22/2003CN1451014A Peptidomimetic protease inhibitors
10/22/2003CN1450903A Processes for preparing clarithromycin polymorphs
10/22/2003CN1125047C Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy) ethylamino]-2-propanole process for its preparation and pharmaceutical use
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635665 Acute respiratory distress syndrome and chronic obstructive pulmonary disease
10/21/2003US6635649 Piperazinedione compounds
10/21/2003CA2288003C Pharmaceutical compositions of tizoxanide and nitazoxanide
10/21/2003CA2208714C Bone mass anabolic composition comprising olpadronate
10/21/2003CA2098020C Anti-viral compounds
10/16/2003WO2003084479A2 Large scale methods of producing adenovirus and adenovirus seed stocks
10/16/2003WO2003084471A2 Compositions selective for adenosine diphosphate and methods of using same
10/16/2003WO2003084465A2 Modeling biological systems
10/16/2003WO2003084463A2 Apparatus for moxa cautery
10/16/2003WO2003049677A3 Mesoporous permeation layers for use on active electronic matrix devices
10/16/2003WO2003030830A3 Method and apparatus for improved stiffness in the linkage assembly of a flexible arm
10/16/2003WO2003028634A3 Method of treatment using ligand-immunogen conjugates
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/16/2003US20030195261 Administering racemic or optically pure sibutramine metabolite, or a pharmaceutically acceptable salt, solvate, or clathrate for prophylaxis or therapy
10/16/2003US20030194725 Creating a database of related protein/nucleic acid sequences with annotations of the potential disease associations of the sequences; testing the potential disease associations by means of a biological assay and validating the disease association
10/16/2003US20030194456 Extract of the leaves and/or stem of Argemone mexicana plant for treatment of psoriasis and related biochemical and immunological disorders
10/16/2003US20030194452 Improved herbal composition having antiallergic properties and a process for the preparation thereof
10/16/2003US20030192560 Method and apparatus for dosing single and multi-agent therapy
10/16/2003CA2478932A1 Large scale methods of producing adenovirus and adenovirus seed stocks
10/15/2003EP1352960A1 Antiviral therapy on the basis of RNA interference
10/15/2003EP1352063A2 Receptor nucleic acids and polypeptides
10/15/2003EP1351923A2 Antiperspirant salts for enhanced cosmetic products
10/15/2003EP1351698A2 Herbal composition for angina pectoris, method to prepare same and uses thereof
10/15/2003EP1005332B1 Pharmaceutical composition for reducing production of mcp-1 protein
10/15/2003EP0910383B1 The use of growth factor modulating compounds
10/15/2003CN1449395A Process for preparing azacycloalkanoyl aminothiazoles
10/15/2003CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
10/15/2003CN1448142A Compositions comprising cytosine derivatives for the treatment of cancer
10/15/2003CN1124157C Pharmaceutical compositions
10/14/2003US6632906 Good cohesion and low dermal irritation; comprises ketone groups cross-linked by a polyamine cross- linking agent
10/14/2003CA2225601C New stable pharmaceutical preparation for producing propellant-free aerosols
10/09/2003WO2003082866A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003WO2003082260A2 Tuberculosis treatment using pleuromutilin derivatives
10/09/2003WO2003082202A2 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/09/2003WO2003045466A3 Catheter composition and uses thereof
10/09/2003US20030191337 Crystal of bicalutamide and production method thereof
10/09/2003US20030191148 Macrolides
10/09/2003US20030190309 Novel probiotics for pet food applications
10/09/2003CA2480695A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003CA2479379A1 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/08/2003EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/08/2003EP1278411A4 Reactive nanoparticles as destructive adsorbents for biological and chemical contamination
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003CN1447817A Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts
10/08/2003CN1447694A Rapid onset formulation
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630514 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
10/07/2003US6630480 Methods of treating leukemia
10/07/2003US6630472 Compounds, pharmaceutical compositions, and methods for stimulating neuronal growth and elongation
10/07/2003US6630162 Pharmaceutical formulation and its use
10/07/2003CA2094808C Oxysulfonyl urea acat inhibitors
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/02/2003WO2003080580A2 Quinoline derivatives and their use as 5-ht6 ligands
10/02/2003WO2003045912A8 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/02/2003WO2003020206A3 Use of atazanavir in hiv therapy
10/02/2003WO2003018031A3 Single dose azithromycin for treating respiratory infections
10/02/2003US20030187025 Benzothiophenes, formulations containing same, and methods
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186945 Method of preparing and use of prodrugs of betulinic acid derivatives
10/02/2003US20030185918 First ingredient obtainable from turmeric; a second ingredient obtainable from ginger; and a third ingredient obtainable from horseradish; treating viral infections
10/02/2003US20030185912 Anti-microbial compositions and methods of using same
10/02/2003US20030185905 Plant extracts for the treatment of increased bone resorption
10/02/2003US20030185791 TNF-derived peptides for use in treating oedema
10/02/2003US20030183963 Ceramic material for dental applications and a method for the production thereof
10/01/2003EP1348709A2 Thiazolo (4,5-D) pyrimidine compounds
10/01/2003EP1348438A1 Compositions comprising d-chiro-inositol for treating hyperlipidemia
10/01/2003EP1348429A2 Melt-extruded orally administrable opioid formulations
10/01/2003EP1347981A1 Condensed purine derivatives as a 1? adenosine receptor antagonists
10/01/2003EP1347980A1 Compounds specific to adenosine-a1,-a2a, and- a3-receptor and uses thereof
10/01/2003EP1347765A2 Dermatological formulations
10/01/2003EP1000029B1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
10/01/2003EP0966448B1 Pyrazine compounds
10/01/2003EP0914098B1 Multi-layered osmotic device
10/01/2003CN1446232A Anionic vinyl/dicarboxylic acid polymers and uses thereof
10/01/2003CN1446211A Indole derivatives useful for treatment of CNS disorders
10/01/2003CN1446207A Process for preparation of baccatin Ôàó derivatives
10/01/2003CN1446104A Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
10/01/2003CN1446094A Method for obtaining antigenic structures enhancing specific cross reactivity
10/01/2003CN1446089A Pharmaceutical composition containing citalopram
10/01/2003CN1446086A Use of estramustine phosphate in treatment of bone metastasis
10/01/2003CN1446074A Epilatory compositions
09/2003
09/30/2003US6627602 Preventing desensitization of receptors
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003CA2100086C Compositions and methods for alleviating menopausal symptoms
09/25/2003WO2003077858A2 Humanized antibodies that recognize beta amyloid peptide
09/25/2003WO2003077830A2 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
1 ... 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 ... 295